NutriLeads wins funding for top-class innovators from European Innovation Council

Nutrileads 29 maart 2018
March 29, Wageningen, The Netherlands. NutriLeads, a Dutch Health Ingredients company announces that its NUTRI-NEED project has been selected for €2.5 million funding under the European Innovation Council SME Instrument (phase 2). The aim of the 2-year project is to prepare NutriLeads' health promoting food ingredient NL-01 for commercialization.

NutriLeads is a dynamic clinical-stage Health Ingredients company that develops crop-derived food ingredients with clinically proven health benefits for specific patient and consumer groups.

NutriLeads' most advanced product, NL-01, is a unique proprietary carrot-derived fibre under development to support immune function and improve resistance to respiratory infections. It has been successfully tested in preclinical models and in a proof of concept study in healthy volunteers. It is currently being studied in a clinical trial to assess its protective effect against an experimental common cold infection.

Ruud Albers, NutriLeads' CEO comments: "The NUTRI-NEED project will accelerate the development of our food ingredient NL-01 and specifically it will allow NutriLeads to further scale-up the production process, obtain market access for Europe, perform a large clinical study in older adults (65+) with increased infection risk and prepare NL-01 for commercialization."

The international jury of investors, entrepreneurs and business experts involved in the assessment of the proposals commented on the NUTRI-NEED project: "The idea, if successful, has huge potential to disrupt the market. It also has the potential to enhance Europe's standing in the health supplement market vis a vis the United States. The IPR strategy is strong and well-implemented. The project has a very impressive team coming from the big players in the industry. They are experts in diverse fields that complement each other within the team."

- - - - - - -

For more information please contact:
Ruud Albers, PhD
Chief Executive Officer, NutriLeads B.V.
+31 (0)651 304 491
ruud.albers@nutrileads.com
www.nutrileads.com

or

Erik Dam, MSc, MBA
Chief Business Officer, NutriLeads B.V.
+31 (0)611 708 525
erik.dam@nutrileads.com
www.nutrileads.com

About NutriLeads
NutriLeads is a dynamic clinical-stage Health Ingredients company developing crop-derived food ingredients with clinically proven health benefits for specific patient and consumer groups. The Company's proprietary ingredients support human physiology, beneficially modulate the gut microbiome, and are naturally sustainable.
All of NutriLeads' proprietary ingredients undergo clinical trials to demonstrate their beneficial impact on health before being licensed out to partner companies who will incorporate them in their finished (food) products. The most advanced ingredient, NL-01 is under development to support immune function and increase resistance to respiratory infections.
NutriLeads is privately held and backed by investors including Thuja Capital, DSM Venturing, PPM Oost and SHIFT Invest. It has also received non-dilutive funding from various regional, national and European grants, including Eurostars and EFRO.
The Company is headquartered in Wageningen, the Netherlands, a world-renowned center for nutrition & health research and development, also known as 'Food Valley'.
For more information, please visit the website: www.nutrileads.com

About SME instrument
The SME Instrument is now part of the European Innovation Council (EIC) pilot that supports top-class innovators, entrepreneurs, small companies and scientists with funding opportunities and acceleration services. The main focus of the EIC pilot is on radical, market-creating innovations to improve productivity and international competitiveness and generate new jobs and higher standards of living.
For more information: https://ec.europa.eu/easme/en/sme-instrument



Back


Share this article:

Contact us

Laan van Kronenburg 14
1183 AS Amstelveen
T 020 3032071
E info@shiftinvest.com
KvK: 61295922